We characterized immunoglobulin heavy chain (IGH) gene rearrangements and searched for clusters of stereotyped B-cell receptors in 123 patients with Waldenström macroglobulinemia (WM; n = 59) or immunoglobulin M monoclonal gammopathy of undetermined significance (IgM-MGUS) (n = 64). A productive monoclonal IGHV-D-J rearrangement was obtained in 99/123 patients (80%). Immunoglobulin heavy chain variable (IGHV) genes were mutated in 94/99 patients (95%) with a median somatic hypermutation rate of 6.7% (2.1-14.5). Compared with the normal B-cell repertoire, patients with WM/IgM-MGUS showed an over-representation of the IGHV3 subgroup (83% vs. 55%, p < 0.0001) and an under-representation of IGHV1 (7% vs. 14%, p = 0.04) and IGHV4 (7% vs. 23%, p ...
A study has shown that MYD88 (L265P) is a recurring somatic mutation in Waldenstr\uf6m\u2019s macrog...
Abstract: Waldenström’s macroglobulinemia (WM) is a relatively uncommon, indolent malig-nancy of imm...
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowle...
We characterized immunoglobulin heavy chain (IGH) gene rearrangements and searched for clusters of s...
We characterized immunoglobulin heavy chain (IGH) gene rearrangements and searched for clusters of s...
Although information about the molecular pathogenesis of Waldenström macroglobulinemia (WM) has sign...
Waldenström Macroglobulinemia (WM) is a B-cell lymphoma characterized by the precursor condition IgM...
Waldenström Macroglobulinemia (WM) is a B-cell lymphoma characterized by the precursor condition Ig...
Histopathology and phenotypic considerations in IgM-secreting B-cell tumors allow distinction betwee...
Waldenstr\uf6m macroglobulinemia (WM) (symptomatic and indolent) and immunoglobulin M (IgM) monoclon...
Histopathology and phenotypic considerations in IgM-secreting B-cell tumors allow distinction betwee...
International audienceTo clarify the relationships between marginal zone lymphomas (MZLs) and Walden...
By whole-genome and/or Sanger sequencing, we recently identified a somatic mutation (MYD88 L265P) th...
We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or Ig...
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowle...
A study has shown that MYD88 (L265P) is a recurring somatic mutation in Waldenstr\uf6m\u2019s macrog...
Abstract: Waldenström’s macroglobulinemia (WM) is a relatively uncommon, indolent malig-nancy of imm...
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowle...
We characterized immunoglobulin heavy chain (IGH) gene rearrangements and searched for clusters of s...
We characterized immunoglobulin heavy chain (IGH) gene rearrangements and searched for clusters of s...
Although information about the molecular pathogenesis of Waldenström macroglobulinemia (WM) has sign...
Waldenström Macroglobulinemia (WM) is a B-cell lymphoma characterized by the precursor condition IgM...
Waldenström Macroglobulinemia (WM) is a B-cell lymphoma characterized by the precursor condition Ig...
Histopathology and phenotypic considerations in IgM-secreting B-cell tumors allow distinction betwee...
Waldenstr\uf6m macroglobulinemia (WM) (symptomatic and indolent) and immunoglobulin M (IgM) monoclon...
Histopathology and phenotypic considerations in IgM-secreting B-cell tumors allow distinction betwee...
International audienceTo clarify the relationships between marginal zone lymphomas (MZLs) and Walden...
By whole-genome and/or Sanger sequencing, we recently identified a somatic mutation (MYD88 L265P) th...
We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or Ig...
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowle...
A study has shown that MYD88 (L265P) is a recurring somatic mutation in Waldenstr\uf6m\u2019s macrog...
Abstract: Waldenström’s macroglobulinemia (WM) is a relatively uncommon, indolent malig-nancy of imm...
There exists a wide spectrum of IgM-secreting B-cell tumors with different clinical behavior. Knowle...